puromycin
CHEBI:17939 EXACT SEEDED antibacterialcytotoxicenzyme inhibitortoxin
What these status tags mean
Curation status describes a workflow state. SEEDED means the record entered through the source-seeding workflow; it does not imply that no later curation occurred. PROPOSED marks an addition awaiting review; REVIEWED records curator sign-off on identity, structure, filing class and producer claims; DEPRECATED retains a superseded or out-of-scope record. These are workflow decisions, not independently verified human review. Agent-assisted contributions may appear in the record history.
Grounding describes the identifier mapping: EXACT uses an ontology identity asserted by the source; MINTED keeps a local identifier when no defensible ontology identity is available; REVIEW_NEEDED flags an exact structure whose ontology identity needs adjudication. The grounding note retains any unresolved alternatives. These tags do not establish the strength of producer or activity evidence.
An aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome.
Structure
| Standard InChIKey | RXWNCPJZOCPEPQ-NVWDDTSBSA-N |
|---|---|
| SMILES | [H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@@H]1[C@@H](CO)O[C@H]([C@@H]1O)N1C=NC2=C1N=CN=C2N(C)C |
| Stereochemistry | fully defined |
| Cross-references | npatlas:NPA02054, pubchem:439530 |
Filing pathway
Carbohydrates — computed by NPClassifier npclassifier.gnps2.org@2026-09-07, which is why it is pinned rather than recomputed. The gene cluster's asserted class is other, from MIBiG.
Producer organisms 1
A claim that this taxon makes the compound. The basis says what the evidence addressed — a knockout and a database assertion are not the same claim.
| Taxon | Basis | Cluster | Evidence |
|---|---|---|---|
| Streptomyces alboniger NCBITaxon:132473 |
SOURCE_ASSERTION | mibig:BGC0000878 | PMID:8576156 |
Occurrences 11
Somebody found the compound in this organism and cited it. That is not a claim that the organism makes it, and nothing here promotes one to the other.
| Taxon | Source | Reference |
|---|---|---|
| Streptomyces NCBITaxon:1883 |
LOTUS | DOI:10.1021/ACS.JNATPROD.7B00850 |
| Streptomyces lividans NCBITaxon:1916 |
LOTUS | DOI:10.1016/S0014-5793(97)01564-0 |
| Acronychia pubescens NCBITaxon:273126 |
LOTUS | DOI:10.1021/ACS.JNATPROD.8B00956 |
| Streptomyces alboniger NCBITaxon:132473 |
LOTUS | DOI:10.1016/S0014-5793(97)01564-0 |
| Streptomyces alboniger NCBITaxon:132473 |
LOTUS | DOI:10.1016/S0014-5793(98)01228-9 |
| Streptomyces alboniger NCBITaxon:132473 |
LOTUS | DOI:10.1021/BI00348A036 |
| Streptomyces alboniger NCBITaxon:132473 |
LOTUS | DOI:10.1074/JBC.271.3.1579 |
| Streptomyces alboniger NCBITaxon:132473 |
LOTUS | DOI:10.1111/J.1432-1033.1993.TB18454.X |
| Streptomyces alboniger NCBITaxon:132473 |
LOTUS | DOI:10.1128/AAC.8.6.721 |
| Streptomyces alboniger NCBITaxon:132473 |
LOTUS | DOI:10.1128/JB.175.22.7474-7478.1993 |
| Streptomyces alboniger NCBITaxon:132473 |
LOTUS | DOI:10.7164/ANTIBIOTICS.38.1761 |
Biosynthetic gene clusters 1
| Accession | Host | Locus evidence | Genome |
|---|---|---|---|
| mibig:BGC0000878 | Streptomyces alboniger NCBITaxon:132473 |
CLUSTER_UNSTATED | genbank:X92429.1 |
A locus claim and a taxon claim are different questions. Heterologous expression settles the first and leaves the second where the isolation report left it.
Mechanism & Biosynthesis Overview
Bioactivities 25
Entries preserve source qualifiers, targets and evidence. Repeated assay names or values are not independent replications; inspect source detail for differences.
| Assay | Result | Target enzyme | Source detail |
|---|---|---|---|
| Constitutive androstane receptor (CAR) small molecule agonists, cell-based qHTS assay in HepG2 cells | OTHER 2.31 uM; INACTIVE | Not recorded | pubchem.aid:2202728
|
| Constitutive androstane receptor (CAR) small molecule agonists, cell-based qHTS assay in HepG2 cells | OTHER 2.31 uM; INACTIVE | Not recorded | pubchem.aid:2202728
|
| Cytochrome P450 family 2 subfamily C member 9 (CYP2C9) small molecule antagonists: luciferase cell-based qHTS assay | OTHER 23.9185 uM; NOT_DETERMINED | Not recorded | pubchem.aid:1645842
|
| Cytochrome P450 family 3 subfamily A member 4 (CYP3A4) small molecule antagonists: luciferase cell-based qHTS assay | OTHER 9.5221 uM; ACTIVE | Not recorded | pubchem.aid:1645841
|
| Cytochrome P450 family 3 subfamily A member 7 (CYP3A7) small molecule antagonists: luciferase cell-based qHTS assay | OTHER 23.9185 uM; ACTIVE | Not recorded | pubchem.aid:1963596
|
| Cytochrome P450 family 3 subfamily A member 7 (CYP3A7) small molecule antagonists: luciferase cell-based qHTS assay | OTHER 23.9185 uM; ACTIVE | Not recorded | pubchem.aid:1963596
|
| GF-AFC viability counterscreen for inhibitors of alpha-synuclein gene (SNCA) expression | OTHER 21.1923 uM; NOT_DETERMINED | Not recorded | pubchem.aid:1671193
|
| P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | OTHER 29.0929 uM; NOT_DETERMINED | Not recorded | PMID:31515284
|
| Primary fluorescence-based thiol-reactive (MSTI) qHTS assay for identification of artifact compounds. | OTHER 13.3714 uM; INACTIVE | Not recorded | pubchem.aid:1845221
|
| Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an RCH-ACV wild type WT cells (2C) | OTHER 0.2582 uM; ACTIVE | Not recorded | pubchem.aid:1645877
|
| Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an RCH-ACV wild type WT cells (2C) | OTHER 0.2582 uM; ACTIVE | UniProtKB:O96028 | pubchem.aid:1645877
|
| Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an isogenic RCH-ACV NSD2 p.E1099K mutant (9B) | OTHER 0.4093 uM; ACTIVE | Not recorded | pubchem.aid:1645876
|
| Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an isogenic RCH-ACV NSD2 p.E1099K mutant (9B) | OTHER 0.4093 uM; ACTIVE | UniProtKB:O96028 | pubchem.aid:1645876
|
| Primary qHTS for small molecule compounds that upregulate eGFP-tagged delta133p53alpha (in N-terminal) cells. | OTHER 6.7456 uM; ACTIVE | Not recorded | pubchem.aid:2060322
|
| Primary qHTS for small molecule compounds that upregulate eGFP-tagged delta133p53alpha (in N-terminal) cells. | OTHER 6.7456 uM; ACTIVE | Not recorded | pubchem.aid:2060322
|
| Primary qHTS to identify anti-liver cancer compounds using libraries of approved drugs and bioactive compounds | OTHER 1.2589 uM; ACTIVE | Not recorded | pubchem.aid:2202548
|
| Viability qHTS for spleen associated tyrosine kinase inhibitor (SYKi) drug resistant MV4-11 cells | OTHER 0.1836 uM; ACTIVE | Not recorded | pubchem.aid:1963824
|
| Viability qHTS for spleen associated tyrosine kinase inhibitor (SYKi) drug resistant MV4-11 cells | OTHER 0.1836 uM; ACTIVE | UniProtKB:P43405 | pubchem.aid:1963824
|
| Viability qHTS for spleen associated tyrosine kinase inhibitor (SYKi) naive MV4-11 cells | OTHER 0.2311 uM; NOT_DETERMINED | Not recorded | pubchem.aid:1963823
|
| Viability qHTS for spleen associated tyrosine kinase inhibitor (SYKi) naive MV4-11 cells | OTHER 0.2311 uM; NOT_DETERMINED | UniProtKB:P43405 | pubchem.aid:1963823
|
| Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | ACTIVE | Not recorded | PMID:31498718
|
| GENE-TOX mutagenicity studies | ACTIVE | Not recorded | pubchem.aid:1259408
|
| High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv | ACTIVE | Not recorded | pubchem.aid:1332
|
| Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF | ACTIVE | Not recorded | pubchem.aid:2240
|
| Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 | ACTIVE | Not recorded | pubchem.aid:2330
|
Elsewhere in the fleet
- AntibioticMech — CHEBI:17939 (same structure, same inchikey)
Explore across X-Mech
Provenance
| Source concept | Source | Version |
|---|---|---|
| BGC0000878 | MIBIG | 5 |
| CHEBI:17939 | CHEBI | 3-star |
This page is generated from data/natural_products/carbohydrates/puromycin.yaml, which is generated from the committed inventories. Neither is edited by hand.